Keybanc Maintains Overweight on Elanco Animal Health, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 73.8%

Neg 0% Neu 0% Pos 73.8%

Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $29 to $30.